Ambys Medicines

About

Ambys Medicines is a biotechnology company focused on discovering and developing regenerative and restorative therapies.

South San Francisco,California,United States
51 - 100
https://www.ambys.com

Highlights

Details

Last Funding Type: Corporate Round
Last Funding Money Raised: $80M
Industries: Biotechnology,Medical,Therapeutics
Founded date: Jan 1, 2018
Number Of Employee: 51 - 100
Operating Status: Active
Legal Name: Ambys Medicines, Inc.

Ambys Medicines is a biotechnology company focused on discovering and developing regenerative and restorative therapies. Ambys Medicines is working to fundamentally transform the lives of people suffering from severe liver diseases by creating breakthrough therapies capable of restoring liver function, preventing the progression of liver disease, and treating the devastating complications of liver failure.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

3

$187M

Ambys Medicines has raised a total of $187M in funding over 2 rounds. Their latest funding was raised on Dec 21, 2021 from a Series A round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Dec 21, 2021	Series A	$47M	6	Third Rock Ventures	—	Detail
Aug 8, 2018	Corporate Round	$80M	1	—	—	Detail
Aug 8, 2018	Series A	$60M	2	Takeda Ventures Third Rock Ventures	—	Detail

Investors

Number of Lead Investors

Number of Investors

3

7

Ambys Medicines is funded by 7 investors. Third Rock Ventures and Takeda Ventures are the most recent investors.

Investor Name	Lead Investor	Funding Round
Third Rock Ventures	Yes	Series A
Takeda Ventures	Yes	Series A
Takeda	—	Series A
Alexandria Venture Investments	—	Series A
Laurion Capital Management	—	Series A
Schroders Capital	—	Series A
Smilegate Investment	—	Series A